Skip to main content

Table 2 Overall patient global morphological and functional measures derived from CMR

From: Patients who do not fulfill criteria for hypertrophic cardiomyopathy but have unexplained giant T-wave inversion: a cardiovascular magnetic resonance mid-term follow-up study

CMR parameters

Baseline (n = 71)

Follow-up (n = 71)

T value

p

LA dimension (mm)

32.0 ± 4.4

32.5 ± 4.4

− 3.186

0.002

LVEDD (mm)

47.8 ± 3.7

47.3 ± 4.0

3.216

0.002

LVEF (%)

67.4 ± 6.4

67.8 ± 6.3

− 1.998

0.050

LVEDVI (ml/m2)

56.4 ± 11.8

54.5 ± 12.4

4.303

 < 0.001

LVESVI (ml/m2)

18.6 ± 5.7

17.7 ± 5.5

4.835

 < 0.001

LV CI (L/min/m2)

2.5 ± 0.6

2.4 ± 1.3

2.557

0.013

BSA(m2)

1.85 ± 0.18

1.87 ± 0.18

− 3.690

 < 0.001

LV mass(g)

95.6 ± 29.2

99.1 ± 30.6

− 4.657

 < 0.001

LV mass index(g/m2)

51.7 ± 14.8

52.9 15.3

− 2.846

0.006

ApA (°)

86.3 ± 14.0

84.5 ± 15.6

3.246

0.002

LGE positive(n)

0

4

  

LGE mass(g)

0

3.50,3.27,2.63,2.60

− 2.174

0.048

LGE percent (%)

0

4.4,6.2,3.8,4.4

− 2.010

0.033

  1. LA left atrium, LVEDD left ventricular end diastolic diameter, LVEF left ventricular ejection fraction, LVEDVI left ventricular stroke volume index, LVESVI left ventricle end-systole volume index, CI cardiac index, BSA body surface area, LV mass left ventricular mass, Max LV wall thickness maximum left ventricular wall thickness, LGE late gadolinium enhancement